Mark Sirgo
Chairman bij GENENTA SCIENCE S.P.A.
Vermogen: 121 877 $ op 31-03-2024
Profiel
Mark A.
Sirgo was the founder of Arius Pharmaceuticals, Inc. founded in 2003, where he held the position of Chief Executive Officer in 2004.
Currently, he is the Chief Executive Officer & Director at Corium Pharma Solutions, Inc. since 2023, Chairman at RDD Pharma Ltd.
since 2018, and Chairman at Genenta Science SpA since 2022.
Dr. Sirgo's former jobs include Chief Executive Officer & Director at Aruna Bio, Inc., Vice Chairman at BioDelivery Sciences International, Inc. from 2004 to 2022, Chairman at 9 Meters Biopharma, Inc. from 2020 to 2023, Independent Director at Biomerica, Inc. from 2016 to 2022, and Independent Director at Salix Pharmaceuticals Ltd.
from 2008 to 2015.
He also held the position of Senior Vice President-Global Sales & Marketing at Pharmaceutical Product Development LLC from 1996 to 1999 and Vice President-New Product Marketing at GSK Plc, Glaxo Wellcome, Inc., and Glaxo, Inc. Dr. Sirgo's education includes an undergraduate degree from The Ohio State University and a doctorate degree from Philadelphia College of Pharmacy.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENENTA SCIENCE SPA
0.19% | 19-04-2023 | 34 822 ( 0.19% ) | 121 877 $ | 31-03-2024 |
9 METERS BIOPHARMA, INC.
0.57% | 24-04-2023 | 83 040 ( 0.57% ) | - $ | 31-03-2024 |
Actieve functies van Mark Sirgo
| Bedrijven | Functie | Begin |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Chairman | 01-05-2022 |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Chairman | 04-06-2018 |
Corium Pharma Solutions, Inc.
 Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023. | Chief Executive Officer | 17-01-2023 |
Eerdere bekende functies van Mark Sirgo
| Bedrijven | Functie | Einde |
|---|---|---|
| 9 METERS BIOPHARMA, INC. | Chairman | 17-07-2023 |
| BIOMERICA, INC. | Director/Board Member | 07-12-2022 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Chief Executive Officer | 02-01-2018 |
| SALIX PHARMACEUTICALS, LTD. | Director/Board Member | 01-04-2015 |
Arius Pharmaceuticals, Inc.
 Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arius Pharmaceuticals, Inc. develops pharmaceuticals for surgical and oncology patients. The firm offers treatments for rapid, oral delivery of sedation, and pain relief of surgical and oncology patients. The firm was founded by Andrew Finn and Mark A. Sirgo in 2003 and is located in Morrisville, NC | Chief Executive Officer | 01-08-2004 |
Opleiding van Mark Sirgo
| The Ohio State University | Undergraduate Degree |
| Philadelphia College of Pharmacy | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| BIOMERICA, INC. | Health Technology |
| GSK PLC | Health Technology |
| GENENTA SCIENCE S.P.A. | Health Technology |
| 9 METERS BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Arius Pharmaceuticals, Inc.
Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arius Pharmaceuticals, Inc. develops pharmaceuticals for surgical and oncology patients. The firm offers treatments for rapid, oral delivery of sedation, and pain relief of surgical and oncology patients. The firm was founded by Andrew Finn and Mark A. Sirgo in 2003 and is located in Morrisville, NC | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| Glaxo, Inc. | |
Aruna Bio, Inc.
 Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Health Services |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Health Technology |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023. | Commercial Services |
